Qorvo Develops Point-of-Care Diagnostic Platform using its Acoustic Resonator Technology

Qorvo Develops Point-of-Care Diagnostic Platform using its Acoustic Resonator Technology

Qorvo has announced the development of a veterinary point-of-care (POC) diagnostic platform for Zomedica Pharmaceuticals Corp. (Zomedica). The Zomedica TRUFORMA POC platform, based on Qorvo’s acoustic resonators have now completed final verification. TheTRUFORMA platform uses Qorvo's differentiated sensors, derived from the fundamental bulk acoustic wave (BAW) technology that is deployed in approximately 2 billion devices worldwide. In this new POC application, Qorvo combines expertise in RF devices, microfluidics, and medical test platform integration. 

Qorvo Biotechnologies LLC, a wholly-owned subsidiary of Qorvo US, Inc. had signed a development and supply agreement in 2018 with Zomedica for its POC platform to be tested for veterinary use. Under the agreement, Qorvo is responsible for developing the POC diagnostic instrument and related assay cartridges, while Zomedica is responsible for the validation, marketing and sale of the assays, instruments, and related assay cartridges.

James Klein, president of Qorvo Infrastructure and Defense Products, commented that this milestone is the culmination of six years of intensive research, development, and application of their proven RF technology to fast and accurate point-of-care diagnostics. While their focus has been on the immunoassay market, they see the potential to use this capability for molecular diagnostics, enabling a dual-use POC platform for rapid and accurate identification of infectious diseases in humans including viral pathogens.

Using acoustic resonators introduces a compelling and proven technology to the veterinary diagnostics market, offering a differentiated detection technique from existing optical or fluorescence methods. Qorvo’s acoustic-resonator-based POC solution testing indicates higher sensitivity than these traditional detection methods, offering performance and accuracy at the point-of-care that is similar to central lab testing.

The Qorvo testing platform is an investigational technology currently limited to investigational use and is not available for sale.

Publisher: everything RF
Tags:-   BAWResonatorMedical

Qorvo

  • Country: United States
More news from Qorvo